Research programme: siderophore acylaminopenicillins - Grunenthal/Hans Knoll InstituteAlternative Names: HKI 9924067; HKI 9924109; HKI 9924129; HKI 9924154; HKI 9924155; Siderophore acylaminopenicillins - Grunenthal/Hans Knoll Institute
Latest Information Update: 05 Mar 2006
At a glance
- Originator Grunenthal; Hans Knoll Institute for Natural Products Research
- Class Penicillins
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Gram-negative infections
Most Recent Events
- 11 Jan 2002 Preclinical development for Gram-negative infections in Germany (Unknown route)